Pyrrolopyridinone compounds and methods for treating HIV
申请人:ViiV Healthcare UK Limited
公开号:US09012642B2
公开(公告)日:2015-04-21
Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
PYRROLOPYRIDINONE COMPOUNDS AND METHODS FOR TREATING HIV
申请人:VIIV Healthcare UK Limited
公开号:EP2757887B1
公开(公告)日:2017-04-26
US9012642B2
申请人:——
公开号:US9012642B2
公开(公告)日:2015-04-21
[EN] PYRROLOPYRIDINONE COMPOUNDS AND METHODS FOR TREATING HIV<br/>[FR] COMPOSÉS PYRROLOPYRIDINONES ET MÉTHODES DE TRAITEMENT DU VIH
申请人:GLAXOSMITHKLINE LLC
公开号:WO2013043553A1
公开(公告)日:2013-03-28
Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).